MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil &
Gas, Inc. (OTCPink: FOGC), today announced that the company has
initiated filing for a voluntary name and symbol change with FINRA
and the state of Wyoming. The
change to Manzo Pharmaceuticals was filed with the state already
and the company is in the process of providing FINRA the necessary
documents to get it approved. The process has a 60 day deadline,
but Manzo Pharmaceuticals feels it will be completed much sooner
than that. The company has also put together a strategy to improve
the share structure in an effort to get Manzo Pharmaceuticals off
ground and moving along the way the company should be.
With the help of market consultants, Manzo is also in the
process of laying out a complete strategy to decrease the number of
outstanding shares, and even more importantly, the float. This
strategy will include buying back blocks of restricted and free
trading stock held by former affiliates, as well as buying back
shares in the open market. The company is also examining several
traditional methods of raising a block of funding to allot to this
cause including several types of registrations and offerings that
will not unnecessarily dilute the float, which would be counter
productive to its cause. He explains, "I want everyone to know that
shareholder value is very important to me, and I will do whatever I
can to increase the value of this company for its shareholders to
the level it really should be."
Overall the company is focusing on its strategy for the next
twelve months in all areas of the business, not just the marketing
and release of new products, but the reduction of shares resulting
from past dilution and whatever else it takes to help Manzo
Pharmaceuticals provide shareholder value, while bringing much
needed remedies and treatments to the people who need them.
About Fortune Oil & Gas, Inc.
Fortune Oil & Gas, Inc. owns and operates Manzo
Pharmaceuticals, a specialty pharmaceutical company engaged in the
research, development, and testing of patented and non-patented
solutions and remedies. Most notably is a patented solution for
lactose Intolerance, and a natural remedy for colic in babies. For
more information follow the company on twitter at @manzopharma, and
visit www.manzopharma.com.
DISCLAIMER:
This Press Release may contain certain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The Company has tried,
whenever possible, to identify these forward-looking statements
using words such as "anticipates," "believes," "estimates,"
"expects," "plans," "intends," "potential" and similar expressions.
These statements reflect the Company's current beliefs and are
based upon information currently available to it. Accordingly, such
forward-looking statements involve known and unknown risks,
uncertainties and other factors which could cause the Company's
actual results, performance or achievements to differ materially
from those expressed in or implied by such statements. The Company
undertakes no obligation to update or advise in the event of any
change, addition or alteration to the information catered in this
Press Release including such forward-looking statements.
SOURCE Fortune Oil & Gas, Inc.
